Dashboard
Manage Tickers

RNAZTranscode Therapeutics, Inc.

Nasdaq transcodetherapeutics.com


$ 0.85 $ -0.36 (-29.75 %)    

Monday, 13-May-2024 11:04:46 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 443.34 $ -0.27 (-0.06 %)
DIA $ 395.62 $ -0.86 (-0.22 %)
SPY $ 521.29 $ -1.30 (-0.25 %)
TLT $ 90.40 $ 0.06 (0.07 %)
GLD $ 216.25 $ -1.00 (-0.46 %)
$ 1.41
$ 1.21
$ 0.00 x 0
$ 0.00 x 0
$ 0.85 - $ 1.23
$ 0.42 - $ 309.60
13,272,525
na
252,398
$ -65.39
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-01-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-31-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-16-2022 03-31-2022 10-Q
9 03-31-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-23-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

transcode-therapeutics-earlier-issued-open-letter-to-shareholders-asks-shareholders-to-give-co-authorization-to-effect-a-reverse-stock-split-as-a-last-resort-incase-the-nasdaq-panel-hearing-recommends-shares-to-be-delisted
TransCode Therapeutics Earlier Issued Open...
05/13/2024 14:54:53

The Board and Management of TransCode Therapeutics (NASDAQ:RNAZ) today issued the following open letter to shareholders of the ...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
05/13/2024 12:06:42

hc-wainwright--co-reiterates-buy-on-transcode-therapeutics-maintains-3-price-target
HC Wainwright & Co. Reiterates Buy on Tran...
04/16/2024 14:53:06

HC Wainwright & Co. analyst Emily Bodnar reiterates TransCode Therapeutics (NASDAQ:RNAZ) with a Buy and maintains $3 pri...

transcode-therapeutics-announces-fda-clearance-to-initiate-phase-12-clinical-trial-with-ttx-mc138-in-patients-with-advanced-solid-tumors
TransCode Therapeutics Announces FDA Clear...
04/15/2024 13:03:22

hc-wainwright--co-reiterates-buy-on-transcode-therapeutics-maintains-3-price-target
HC Wainwright & Co. Reiterates Buy on Tran...
04/03/2024 16:03:31

HC Wainwright & Co. analyst Emily Bodnar reiterates TransCode Therapeutics (NASDAQ:RNAZ) with a Buy and maintains $3 pri...

transcode-therapeutics-and-akribion-genomics-report-proof-of-concept-laboratory-studies-in-human-cells-say-studies-to-date-suggest-that-akribions-g-dase-e-ribonucleoprotein-complexes-could-be-conjugated-to-transcodes-ttx-delivery-platform-suggesting-that-the-drug-candidate-could-be-formulated-as-intended
TransCode Therapeutics and Akribion Genomi...
03/11/2024 13:01:42

transcode-therapeutics-reports-publication-of-us-patent-application-titled-nanoparticles-and-template-directed-rig-i-agonist-precursor-compositions-and-uses-thereof-for-cancer-therapy
TransCode Therapeutics Reports Publication...
02/20/2024 13:08:30

transcode-therapeutics-filed-us-patent-application--20240042070-nanoparticles-and-template-directed-rig-i-agonist-precursor-compositions-and-uses-thereof-for-cancer-therapy
Transcode Therapeutics Filed U.S. Patent A...
02/08/2024 21:03:34

why-nextracker-shares-are-trading-higher-by-around-20-here-are-20-stocks-moving-premarket
Why Nextracker Shares Are Trading Higher B...
02/01/2024 12:51:14

Shares of Nextracker Inc. (NASDAQ: NXT) rose sharply during today’s pre-market trading after the company reported better-than-...

transcode-therapeutics-regained-compliance-with-nasdaq
TransCode Therapeutics Regained Compliance...
01/31/2024 21:55:18

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
01/31/2024 21:31:06

looking-into-transcode-therapeuticss-recent-short-interest
Looking Into TransCode Therapeutics's Rece...
01/29/2024 18:30:20

transcode-therapeutics-collaborates-with-debiopharm-financial-terms-not-disclosed
TransCode Therapeutics Collaborates With D...
01/29/2024 13:40:49

The collaboration will explore combining TransCode's proprietary TTX delivery platform with Debiopharm's expertise in t...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
01/22/2024 21:31:12

why-transcode-therapeutics-shares-are-trading-lower-by-over-24-here-are-other-stocks-moving-in-fridays-mid-day-session
Why TransCode Therapeutics Shares Are Trad...
01/19/2024 18:05:18

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
01/19/2024 17:31:10

transcode-therapeutics-shares-resume-trade
TransCode Therapeutics Shares Resume Trade
01/18/2024 18:38:56

transcode-therapeutics-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down--44
TransCode Therapeutics Shares Halted On Ci...
01/18/2024 18:30:17

transcode-therapeutics-announces-pricing-of-725m-public-offering-of-5942623-shares-of-its-common-stock-at-a-price-of-122share
TransCode Therapeutics Announces Pricing O...
01/18/2024 18:29:03

TransCode Therapeutics, Inc. (NASDAQ:RNAZ) (the "Company"), an RNA oncology company committed to more effectively treat...

transcode-therapeutics-files-for-offering-up-to-35m-shares-of-common-stock-together-with-common-stock-purchase-warrants
TransCode Therapeutics Files For Offering ...
01/18/2024 15:43:50

- SEC Filing

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION